title: ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures.
abstract: As the mortality associated with invasive Candida infections remains high, it is important to make optimal use of available diagnostic tools to initiate antifungal therapy as early as possible and to select the most appropriate antifungal drug. A panel of experts of the European Fungal Infection Study Group (EFISG) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) undertook a data review and compiled guidelines for the clinical utility and accuracy of different diagnostic tests and procedures for detection of Candida infections. Recommendations about the microbiological investigation and detection of candidaemia, invasive candidiasis, chronic disseminated candidiasis, and oropharyngeal, oesophageal, and vaginal candidiasis were included. In addition, remarks about antifungal susceptibility testing and therapeutic drug monitoring were made.
authors.affiliation: Servicio de Micología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain. mcuenca-estrella@isciii.es
authors.forename: M
authors.initials: M
authors.lastname: Cuenca-Estrella
authors.forename: P E
authors.initials: PE
authors.lastname: Verweij
authors.forename: M C
authors.initials: MC
authors.lastname: Arendrup
authors.forename: S
authors.initials: S
authors.lastname: Arikan-Akdagli
authors.forename: J
authors.initials: J
authors.lastname: Bille
authors.forename: J P
authors.initials: JP
authors.lastname: Donnelly
authors.forename: H E
authors.initials: HE
authors.lastname: Jensen
authors.forename: C
authors.initials: C
authors.lastname: Lass-Flörl
authors.forename: M D
authors.initials: MD
authors.lastname: Richardson
authors.forename: M
authors.initials: M
authors.lastname: Akova
authors.forename: M
authors.initials: M
authors.lastname: Bassetti
authors.forename: T
authors.initials: T
authors.lastname: Calandra
authors.forename: E
authors.initials: E
authors.lastname: Castagnola
authors.forename: O A
authors.initials: OA
authors.lastname: Cornely
authors.forename: J
authors.initials: J
authors.lastname: Garbino
authors.forename: A H
authors.initials: AH
authors.lastname: Groll
authors.forename: R
authors.initials: R
authors.lastname: Herbrecht
authors.forename: W W
authors.initials: WW
authors.lastname: Hope
authors.forename: B J
authors.initials: BJ
authors.lastname: Kullberg
authors.forename: O
authors.initials: O
authors.lastname: Lortholary
authors.forename: W
authors.initials: W
authors.lastname: Meersseman
authors.forename: G
authors.initials: G
authors.lastname: Petrikkos
authors.forename: E
authors.initials: E
authors.lastname: Roilides
authors.forename: C
authors.initials: C
authors.lastname: Viscoli
authors.forename: A J
authors.initials: AJ
authors.lastname: Ullmann
mesh_terms: D000935:Antifungal Agents / Q000494:pharmacology* / Q000627:therapeutic use; D015415:Biomarkers / Q000032:analysis; D002175:Candida / Q000187:drug effects / Q000302:isolation & purification*; D002177:Candidiasis / Q000175:diagnosis* / Q000188:drug therapy*; D019317:Evidence-Based Medicine; D006801:Humans; D008826:Microbial Sensitivity Tests
chemical_list: D000935:Antifungal Agents; D015415:Biomarkers